2021 Virtual ESMO Review


 

ESMO 2021 Updates on EBC: Neoadjuvant Carboplatin and Ipatasertib in TNBC, Neoadjuvant Trastuzumab-Lapatinib and Chemo in HER2+ Disease, Extended Adjuvant ET

79 views
November 8, 2021
0 Comments
Login to view comments. Click here to Login